Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Asian Values Regulatory News (FAS)

Share Price Information for Fidelity Asian Values (FAS)

Share Price is delayed by 15 minutes
Get Live Data
570.00    -14.00 (-2.40%)
Bid:
570.00
Ask:
578.00
Spread: 8.00 (1.404%)
Market Cap: £361.57m
FAS Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Asian Values Share Chart

Results analysis from Kepler Trust Intelligence

28 Oct 2025 16:24

RNS Number : 1730F
Fidelity Asian Values PLC
28 October 2025
Ā 

Fidelity Asian Values (FAS)

28/10/2025

Results analysis from Kepler Trust Intelligence

Fidelity Asian Values (FAS) has released its annual results for the year ending 31/07/2025, with a NAV total return of 12.4%, beating its benchmark which returned 7.1%. FAS also outperformed its peer group average return of 7.8%.

Contributors to outperformance stem from a wide range of sources. The top contributor was a semi-conductor firm benefiting from the AI boom, second was an Australian gold mining firm and third was a long-held Vietnamese apparel manufacturer.

Gearing added an additional 250bps to relative performance, though the level was reduced over the period, reflecting the market recovery leading to higher valuations. Derivatives were used to short stocks which also generated additional alpha in the year.

FAS' share price performed well, leading to the discount trading at its narrowest point at the year end. This trend has continued since giving the trust the narrowest discount in the peer group. This has been aided by share buybacks, which added c. 70bps to NAV and have continued post results.

The trust announced a 41.4% increase in its dividend, driven by increase in underlying revenue as well as changes to the charging structure, now split across the capital account and to revenue.

Chair Clare Brady reflected on the good performance, highlighting that the trust: "Has been able to do so well against a backdrop of turmoil and extreme volatility [which] speaks to the fact that the fund offers investors excellent risk diversification" whilst also remaining positive on the outlook, noting the managers "continue to see good prospects for their portfolio of undervalued, quality businesses."

Kepler View

We believe these results are a strong validation of managers Nitin Bajaj and Ajinkya Dhavale's approach, with their contrarian mindset capturing market turning points that have been a feature of the period under review. Asian markets have been through considerable changes in the past year, and the managers' positioning in this environment was favourable, albeit purely a function of their bottom-up, stock selection focus, which has proven its worth. This has reinforced FAS' long-term outperformance of its benchmark which we believe demonstrates the quality of the approach.

Furthermore, the managers remain optimism for the future. Whilst the asset classes' aggregate valuations are at or above long-term averages, Nitin and Ajinkya's portfolio is trading considerably lower than the market on average. The trust's positioning remains highly differentiated too, especially with an allocation to China's 'old economy' stocks and to Indonesia. As such, we believe FAS is a unique proposition that offers diversification benefits and upside potential.

The improved dividend outlook has also been positive in our view. The tweaks to how charges are attributed are small, but have improved the long-term income potential considerably as more can be passed on as dividends, further adding to the trust's appeal.

These factors may well have contributed to the trust's discount narrowing. We think this creates attraction to both the recovery in the region, and the successful strategy of FAS' managers.

CLICK HERE TO READ THE FULL REPORTĀ  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Ā 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Ā 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
NRABLBDGXDDDGUI
Date   Source Headline
22nd Dec 20257:00 amPRNTransaction in Own Shares
19th Dec 20257:38 amRNSNet Asset Value(s)
18th Dec 20255:00 pmRNSTransaction in Own Shares
18th Dec 20255:00 pmPRNTransaction in Own Shares
18th Dec 20258:00 amRNSNet Asset Value(s)
17th Dec 20255:02 pmPRNTransaction in Own Shares
17th Dec 20257:29 amRNSNet Asset Value(s)
16th Dec 20257:30 amRNSNet Asset Value(s)
15th Dec 20257:53 amRNSNet Asset Value(s)
12th Dec 20257:57 amRNSNet Asset Value(s)
11th Dec 20257:32 amRNSNet Asset Value(s)
10th Dec 20257:41 amRNSNet Asset Value(s)
9th Dec 20257:24 amRNSNet Asset Value(s)
8th Dec 20257:48 amRNSNet Asset Value(s)
5th Dec 20255:06 pmPRNTransaction in Own Shares
5th Dec 20257:35 amRNSNet Asset Value(s)
4th Dec 20255:06 pmPRNTransaction in Own Shares
4th Dec 20257:21 amRNSNet Asset Value(s)
3rd Dec 20254:54 pmPRNTransaction in Own Shares
3rd Dec 20257:32 amRNSNet Asset Value(s)
2nd Dec 20255:02 pmPRNTransaction in Own Shares
2nd Dec 20257:32 amRNSNet Asset Value(s)
1st Dec 20252:10 pmPRNTotal Voting Rights
1st Dec 20258:04 amRNSNet Asset Value(s)
28th Nov 20258:16 amRNSNet Asset Value(s)
27th Nov 20257:52 amRNSNet Asset Value(s)
26th Nov 20254:57 pmPRNTransaction in Own Shares
26th Nov 20254:03 pmPRNResult of AGM
26th Nov 20257:44 amRNSNet Asset Value(s)
25th Nov 20255:09 pmPRNTransaction in Own Shares
25th Nov 20253:15 pmPRNMonthly Factsheet
25th Nov 20257:55 amRNSNet Asset Value(s)
24th Nov 20257:42 amRNSNet Asset Value(s)
21st Nov 20255:05 pmPRNTransaction in Own Shares
21st Nov 20257:53 amRNSNet Asset Value(s)
20th Nov 20254:58 pmPRNTransaction in Own Shares
20th Nov 20257:41 amRNSNet Asset Value(s)
19th Nov 20255:01 pmPRNTransaction in Own Shares
19th Nov 20257:51 amRNSNet Asset Value(s)
18th Nov 20255:01 pmPRNTransaction in Own Shares
18th Nov 20257:45 amRNSNet Asset Value(s)
17th Nov 20255:15 pmPRNTransaction in Own Shares
17th Nov 20257:54 amRNSNet Asset Value(s)
14th Nov 20255:16 pmPRNTransaction in Own Shares
14th Nov 20257:52 amRNSNet Asset Value(s)
13th Nov 20257:49 amRNSNet Asset Value(s)
12th Nov 20257:35 amRNSNet Asset Value(s)
11th Nov 20257:40 amRNSNet Asset Value(s)
10th Nov 20257:22 amRNSNet Asset Value(s)
7th Nov 20257:53 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.